Onconic Therapeutics Inc. (KOSDAQ:476060)
13,450
-550 (-3.93%)
Jun 30, 2026, 3:30 PM KST
153.18% (1Y)
| Market Cap | 610.74B +163.1% |
| Revenue (ttm) | 67.20B +196.2% |
| Net Income | 20.33B |
| EPS | 441.04 |
| Shares Out | 45.41M |
| PE Ratio | 30.50 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 154,082 |
| Open | 13,930 |
| Previous Close | 14,000 |
| Day's Range | 13,440 - 13,980 |
| 52-Week Range | 5,188 - 28,900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Mar 20, 2026 |